Director, Chief Executive Officer · Bicara Therapeutics Inc. · Common Stock
Side
M
Value
$156K
Shares
41.2K
Price
$3.79
Executed
Nov 24, 2025
Disclosed
Nov 25, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 24 executedNov 25, 2025 disclosed
BCAX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+8 / 25
$156K reported value · 13.3% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Mazumdar Claire filed this Form 4 reporting a option exercise of BCAX on Nov 24, 2025. It became public on Nov 25, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Mazumdar Clairecik:0002034671
Issuer
Bicara Therapeutics Inc.cik:0002023658
Revision history · 0
No field has changed since this record was first ingested.
